Terms: = Liver cancer AND Ki-67 AND Treatment
341 results:
1. Epithelial-Mesenchymal Transformation Promotes the Progression of Hepatocellular Carcinoma through NF-κB/MMP9 Axis.
Li J; Cai Q; Wang Z; Wang L; Yang G; Zhang Z; Ge N; Hu S; Bai T
Discov Med; 2024 Apr; 36(183):666-677. PubMed ID: 38665016
[TBL] [Abstract] [Full Text] [Related]
2. New treatment alternatives for primary and metastatic colorectal cancer by an integrated transcriptome and network analyses.
Karaca C; Demir Karaman E; Leblebici A; Kurter H; Ellidokuz H; Koc A; Ellidokuz EB; Isik Z; Basbinar Y
Sci Rep; 2024 Apr; 14(1):8762. PubMed ID: 38627442
[TBL] [Abstract] [Full Text] [Related]
3. Abdominopelvic desmoplastic small round cell tumor with metastasis: A case report and literature review.
Chen G; Zhang Q; Xia D
Medicine (Baltimore); 2024 Apr; 103(14):e37664. PubMed ID: 38579065
[TBL] [Abstract] [Full Text] [Related]
4. Lipid-Based Self-Microemulsion of Niclosamide Achieved Enhanced Oral Delivery and Anti-Tumor Efficacy in Orthotopic Patient-Derived Xenograft of Hepatocellular Carcinoma in Mice.
Liu Y; Guerrero DQ; Lechuga-Ballesteros D; Tan M; Ahmad F; Aleiwi B; Ellsworth EL; Chen B; Chua MS; So S
Int J Nanomedicine; 2024; 19():2639-2653. PubMed ID: 38500681
[TBL] [Abstract] [Full Text] [Related]
5. MHY1485 promotes adriamycin sensitivity in HepG2 cells by inhibiting autophagy.
Guo J; Lei Y; Liu L; Wen Z; Zhang B; Fang J; Liang G; Guo Q; Peng J
Funct Integr Genomics; 2024 Feb; 24(1):22. PubMed ID: 38306005
[TBL] [Abstract] [Full Text] [Related]
6. [A Case of Triple Negative Breast cancer with Successful Control of Recurrent Disease Activity for More than Ten Years].
Yabe N; Watanuki R; Harada Y; Kondo A; Yanagisawa T; Maeda H; Kishi M; Yoshikawa T; Osumi K; Kamiya N; Sotome K; Ishii Y; Jinno H; Ikeda T; Watanabe M
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1759-1761. PubMed ID: 38303198
[TBL] [Abstract] [Full Text] [Related]
7. [Antitumor effects of redox-responsive nanoparticles containing platinum（Ⅳ）in ovarian cancer].
Hou HY; Tang DS; Zhang YN; Wang KY; Ao M; Luo HX; Li B
Zhonghua Zhong Liu Za Zhi; 2024 Jan; 46(1):76-85. PubMed ID: 38246783
[No Abstract] [Full Text] [Related]
8. Efficacy, safety, and predictive model of Palbociclib in the treatment of HR-positive and HER2-negative metastatic breast cancer.
Wang W; Lei W; Fang Z; Jiang R; Wang X
BMC Cancer; 2024 Jan; 24(1):1. PubMed ID: 38166784
[TBL] [Abstract] [Full Text] [Related]
9. Characteristics and treatment options of glucagonomas: a national study from the French Group of Endocrine Tumors and ENDOCAN-RENATEN network.
Perrier M; Brugel M; Gérard L; Goichot B; Lièvre A; Lepage C; Hautefeuille V; Do Cao C; Smith D; Thuillier P; Cros J; Cadiot G; Walter T; de Mestier L
Eur J Endocrinol; 2023 Dec; 189(6):575-583. PubMed ID: 38039101
[TBL] [Abstract] [Full Text] [Related]
10. Quantitative SSTR-PET/CT for predicting response and survival outcomes in patients with pancreatic neuroendocrine tumors receiving CAPTEM.
Ingenerf M; Karim H; Auernhammer C; Zacherl M; Wenter V; Winkelmann M; Ricke J; Berger F; Schmid-Tannwald C
Radiol Oncol; 2023 Dec; 57(4):436-445. PubMed ID: 38038419
[TBL] [Abstract] [Full Text] [Related]
11. [Remodeling of tumor stroma combined with photothermal therapy in the treatment of triple-negative breast cancer].
Zhang J; Li Y; Tang YX; Wu FY; Wang SJ
Zhonghua Zhong Liu Za Zhi; 2023 Nov; 45(11):926-933. PubMed ID: 37968077
[No Abstract] [Full Text] [Related]
12. Radiomics in CT and MR imaging of the liver and pancreas: tools with potential for clinical application.
Berbís MÁ; Godino FP; Rodríguez-Comas J; Nava E; García-Figueiras R; Baleato-González S; Luna A
Abdom Radiol (NY); 2024 Jan; 49(1):322-340. PubMed ID: 37889265
[TBL] [Abstract] [Full Text] [Related]
13. Modulation of mammary tumour progression using murine model by ethanol root extract of Saussurea costus (falc.) lipsch.
Kumar R; Bhardwaj P; Soni M; Singh R; Choudhary S; Virmani N; Asrani RK; Patial V; Sharma D; Gupta VK; Tripathi BN
J Ethnopharmacol; 2024 Jan; 319(Pt 3):117302. PubMed ID: 37858751
[TBL] [Abstract] [Full Text] [Related]
14. Optimal first-line treatment strategies of systemic therapy for unresectable gastrointestinal neuroendocrine tumors based on the opinions of Japanese experts.
Honma Y; Ikeda M; Hijioka S; Matsumoto S; Ito T; Aoki T; Furuse J
Invest New Drugs; 2023 Dec; 41(6):777-786. PubMed ID: 37856005
[TBL] [Abstract] [Full Text] [Related]
15. Treating rare tumors with liver transplantation.
Melehy A; Agopian V
Curr Opin Organ Transplant; 2024 Feb; 29(1):30-36. PubMed ID: 37851086
[TBL] [Abstract] [Full Text] [Related]
16. Identification and validation of microtubule depolymerizing agent, CYT997, as a potential drug candidate for hepatocellular carcinoma.
Ahmad F; Ma L; Wei W; Liu Y; Hakim I; Daugherty A; Mujahid S; Radin AA; Chua MS; So S
Liver Int; 2023 Dec; 43(12):2794-2807. PubMed ID: 37833852
[TBL] [Abstract] [Full Text] [Related]
17. Near-infrared photoimmunotherapy in the models of hepatocellular carcinomas using cetuximab-IR700.
Takao S; Fukushima H; King AP; Kato T; Furusawa A; Okuyama S; Kano M; Choyke PL; Escorcia FE; Kobayashi H
Cancer Sci; 2023 Dec; 114(12):4654-4663. PubMed ID: 37817415
[TBL] [Abstract] [Full Text] [Related]
18. [Analysis of clinicopathological features of 18 cases of hepatic angiosarcoma].
Zhou YY; Wang H; Xian ZH; Cong WM; Dong H
Zhonghua Gan Zang Bing Za Zhi; 2023 Jul; 31(7):729-735. PubMed ID: 37580256
[No Abstract] [Full Text] [Related]
19. Anti-cancer effectiveness of a novel ceramide analog on chemo-sensitive and chemo-resistant breast cancers.
Ponnapakkam T; Saulsberry T; Hill-Odom M; Beamon T; Hooks R; Goyal N; Shaik S; Anbalagan M; Foroozesh M
Anticancer Drugs; 2024 Jan; 35(1):12-21. PubMed ID: 37578744
[TBL] [Abstract] [Full Text] [Related]
20. [A Case of Breast Carcinoma That Changed Subtype to Squamous Cell Carcinoma after Chemotherapy].
Konishi K; Araya J; Nagabuchi M; Sakamoto T; Ogino J; Hirano S
Gan To Kagaku Ryoho; 2023 Jul; 50(7):825-827. PubMed ID: 37496230
[TBL] [Abstract] [Full Text] [Related]
[Next]
